Stock exchange and press releases of BBS will be published on these pages. Releases are published in Finnish and in English.
Contact information for the media: info@bbs-artebone.fi from which you can also request additional media material
Archived releases can be found:
2018
2019
2020
2021
09.05.2022 BBS publishes EU growth prospectus in connection to its EUR 4.5 million rights issue
06.05.2022 BBS-Bioactive Bone Substitutes Plc: BBS arranges a rights issue of approximately maximum 4.5 MEUR with additional warrants
29.04.2022 BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2022
05.04.2022 Invitation to the Bbs-Bioactive Bone Substitutes Plc’s Annual General Meeting (AGM)
29.03.2022 BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2021 has been published
17.03.2022 BBS-Bioactive Bone Substitutes Plc: Decisions of the Extraordinary General Meeting 2022
09.03.2022 BBS Bioactive Bone Substitutes Plc has filed the CE-marking application of Artebone® bone void filler to the authorities
24.02.2022 Invitation to the Extraordinary General Meeting of Bbs-Bioactive Bone Substitutes Plc
24.02.2022 BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2021 (unaudited)
23.02.2022 Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position